Craif, spun off from Nagoya University in Japan in 2018, is using microRNA (miRNA) to develop an AI-powered early cancer detection software, and it has raised $22 million in Series C funding to expand further into the U.S. market and bolster its R&D.
Early cancer detection startup Craif raises $22M